Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW 13,330
+50 (0.38%)
Apr 1, 2025, 3:30 PM KST
Osang Healthcare Co.,Ltd Revenue
In the year 2024, Osang Healthcare Co.,Ltd had annual revenue of 80.49B KRW, down -77.38%. Osang Healthcare Co.,Ltd had revenue of 19.37B in the quarter ending December 31, 2024, with 32.73% growth.
Revenue
80.49B
Revenue Growth
-77.38%
P/S Ratio
2.25
Revenue / Employee
240.98M
Employees
334
Market Cap
182.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.49B | -275.36B | -77.38% |
| Dec 31, 2023 | 355.85B | 161.95B | 83.53% |
| Dec 31, 2022 | 193.89B | 61.57B | 46.53% |
| Dec 31, 2021 | 132.33B | -125.64B | -48.70% |
| Dec 31, 2020 | 257.97B | 207.58B | 412.01% |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |